Skip to main content
Compare/E13 vs L92.1

E13 vs L92.1

E13 (Other specified diabetes mellitus) compared with L92.1 (Necrobiosis lipoidica, not elsewhere classified), from the official CMS tabular data. Do not report these codes together: the official tabular list marks them Excludes1.

Can these codes be reported together?

No — do not report together. L92.1 carries an Excludes1 note covering E13: “necrobiosis lipoidica associated with diabetes mellitus (E08-E13 with .620)”

Sole exception: when the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).

Side by side

E13Other specified diabetes mellitusL92.1Necrobiosis lipoidica, not elsewhere classified
Billing statusNon-billable header

Report instead: E13.00, E13.01, E13.10, E13.11, E13.21

Billable
ClassificationE00-E89 — Endocrine, Nutritional and Metabolic Diseases (E00-E89)L00-L99 — Diseases of the Skin and Subcutaneous Tissue (L00-L99)
DefinitionOther specified diabetes mellitus is a non-billable ICD-10-CM category code (E13).Necrobiosis lipoidica, not elsewhere classified is a billable ICD-10-CM diagnosis code (L92.1).
Includes
diabetes mellitus due to genetic defects of beta-cell function
diabetes mellitus due to genetic defects in insulin action
postpancreatectomy diabetes mellitus
postprocedural diabetes mellitus
Use additional code
code to identify control using:
injectable non-insulin antidiabetic drugs (Z79.85)
insulin (Z79.4)

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources